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Over the past years cardiovascular magnetic reso-
nance (CMR) imaging has become one of the most
prominent noninvasive imaging modalities in cardio-
vascular medicine [1–5]. Using CMR imaging, a
wide variety of diseases can be detected varying from
coronary artery disease, myocardial viability, vein
graft disease to congenital heart disease [6–18]. An
interesting application of CMR is the detection and
quantification of infarcted myocardium in humans
and experimental animals by a technique called
delayed-enhancement CMR [19–25]. With this tech-
nique a gadolinium CMR contrast agent is injected
intravenously followed by a long interval in which
the perfused area has lost the contrast, whereas the
infarcted area has slowly gained some contrast and
releases that contrast with a long delay. The infarcted
area is ‘‘enhanced’’ by this delay and this in vivo
determined infarct size has been found to correlate
well with postmortem determined infarct size [26–
28]. Particularly in non-transmural infarction the area
of late gadolinium enhancement correlated only
weakly with the infarct size determined by perfusion
scintigraphy [29]. The occurrence of microvascular
obstruction causes dark zones in the area of late
gadolinium enhancement as appearance of gadolin-
ium is obstructed [30, 31]. Over time, the area of
delayed gadolinium enhancement becomes progres-
sively smaller due to scar formation and hypertrophy
of surviving myocardium. These late gadolinium
enhancement techniques use T1-weighted images and
are used regularly in clinical cardiology and exper-
imental research.
In this issue of the International Journal of
Cardiovascular Imaging, Choi et al. [32] investigated
to which extent useful information is present in T2-
weighted images of porcine hearts with reperfused
myocardial infarction. For over 25 years it is known
that in the acutely infarcted heart the signal intensity in
T2-weighted images correlates well with myocardial
edema [33, 34]. This ‘‘edema imaging’’ on T2-
weighted images was shown to be dependent of infarct
age: edema-associated hyper-intense zones in T2-
weighted images resolved over time and the area of T2
abnormality delineated the area at risk rather than the
infarcted area [35]. In the present study [32], the left
anterior descending artery (LAD) was occluded for 90
or 180 min followed by reperfusion for 90 min. In total
15 pigs were studied of which 9 pigs underwent 90 min
of LAD occlusion followed by 90 min of reperfusion,
whereas the other 6 pigs underwent 180 min of LAD
occlusion followed by 90 min of reperfusion. The
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authors identified two groups of infarcts on the basis of
the T2-weighted images: group A, infarcts with
homogeneous and hyper-intensive signal intensity on
T2-weighted images, and group B, infarcts with iso-,
low-, or heterogeneous signal intensities on T2-
weighted images. In group B infarcts, T2-weighted
images exhibited about twice as large microvascular
obstructions than the T2-weighted images of group A
infarcts. The contrast ratios of T2-weighted images
were inversely correlated to the area of microvascular
obstruction observed in late gadolinium enhancement
images. It has been shown that areas of microvascular
obstruction are usually filled by hemorrhage due to
microvascular damage [36, 37]. Choi and colleagues
found an almost 1:1 relationship between area of
microvascular obstruction and the area of hemorrhage.
Previously, van den Bos et al. [38] reported that signal
voids on T2-weighted images of reperfused infarctions
in porcine hearts were due to the presence of hemor-
rhage. In addition, Choi et al. found a significant
inverse correlation between contrast ratio of T2-
weighted images and area of hemorrhage determined
postmortem. However, T2-weighted images are not
optimal for determination of infarct size as they
overestimate infarct size determined by (1) late
gadolinium enhancement imaging in vivo, and (2)
triphenyl tetrazolium chloride staining postmortem.
Detection of intramyocardial hemorrhage, either
by T2-weighted images or by late gadolinium
enhancement imaging (or myocardial contrast echo-
cardiography), has prognostic value [30, 31, 38].
Patients without hemorrhage showed significant
improvement in wall motion score in the weeks after
acute infarction, whereas left ventricular contractile
function of patients with intra-myocardial hemor-
rhage did not improve at 1 month follow-up [38]. An
advantage of the clinical use of T2-weighted images
is the fact that T2-weighted imaging detects acutely
infarcted myocardium better than chronic infarction,
the latter being assessed best with late gadolinium
enhancement imaging. Finally, the use of gadolin-
ium-based CMR contrast agents is contraindicated in
patients with renal insufficiency (GFR \ 15 ml/min)
as it may precipitate nephrogenic systemic fibrosis
[39]. Therefore, several indications exist to use T2-
weighted images in the setting of the acute myocar-
dial infarction. Whereas decreased T2-weighted
contrast ratios significantly correlate with the extent
of persistent microvascular obstruction and intra-
myocardial hemorrhage, contrast enhanced imaging
may contribute to early detection of myocardial
injury due to myocardial infarction. The study by
Choi et al. [32] underscores therefore the diagnostic
capability of CMR imaging techniques in patients
with acute myocardial infarction.
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